Research only
Back soonTesamorelin
GHRH analogue for pituitary signalling research
€70.00
- Form
- Lyophilised powder
- Amount
- 10 mg vial
- Purity
- ≥ 99 %
- Currently out of stock – back soon
- Sealed, moisture-protected packaging
About this product
Tesamorelin is a synthetic 44-amino-acid peptide, an analogue of human growth hormone-releasing hormone (GHRH 1-44). Supplied as a lyophilised powder in a 10 mg vial for laboratory research.
Structure
- Sequence – identical to native GHRH(1-44), C-terminus amidated.
- N-terminal modification. A trans-3-hexenoic acid group is attached to the first tyrosine. It protects the peptide from enzymatic degradation, making it more stable than native GHRH.
Research areas
- GHRH receptor binding and activation studies in pituitary cell models.
- Regulation of growth hormone release and its signalling pathways (cAMP).
- Stability of modified peptides compared with native GHRH, analytical method development (HPLC, MS).
Packaging
A sealed glass vial with an aluminium crimp cap. Every vial carries a batch number and expiry date.
For laboratory research only. Not for human or animal use.
- Purity confirmed
- Batch certificate of analysis (COA)
| Purity | ≥ 99 % |
|---|---|
| CAS number | 218949-48-5 |
| Molecular formula | C221H366N72O67S |
| Molecular weight | 5135.9 g/mol |
| Sequence length | 44 aa |
Store at 2–8 °C (−20 °C for long-term storage), dry and away from light. Let the vial reach room temperature before opening.
For in-vitro research use only. Not a medicine or food supplement. Not for human or animal use. Research use policy
